ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

NCI, Six Centers Begin Feasibility Study Of Spiral CT For Lung Cancer Screening.

September 8, 2000

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006

NCI’s Future Depends On Recruiting Youth to Careers in Science, NCI Director Says at His Swearing-In Ceremony.

October 20, 2006

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999